Ioannis Panagopoulos1, Ludmila Gorunova2, Marius Lund-Iversen3, Assia Bassarova3, Sverre Heim2,4. 1. Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway ioannis.panagopoulos@rr-research.no. 2. Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. 3. Department of Pathology, Oslo University Hospital, Oslo, Norway. 4. Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Abstract
BACKGROUND/AIM: Malignant chondroid syringoma is a rare tumor of unknown pathogenesis. MATERIALS AND METHODS: Genetic analyses were performed on a malignant chondroid syringoma. RESULTS: G-banding analysis of short-term cultured tumor cells yielded the karyotype 46,Y,t(X;6)(p11;p21)[15]/46,XY[2]. RNA sequencing detected an in-frame fusion of PHF1 from 6p21 with TFE3 from Xp11, verified by RT-PCR and Sanger sequencing. Genomic PCR showed that the PHF1-TFE3 junction was identical to the fusion found by RNA sequencing and RT-PCR. CONCLUSION: Malignant chondroid syringoma is genetically related to tumors with PHF1 rearrangements such as low-grade endometrial sarcoma and ossifying fibromyxoid tumor, but also with tumors having TFE3 rearrangements such as renal cell carcinoma, alveolar soft part sarcoma, PEComa, and epithelioid hemangioendothelioma. Further investigations on malignant chondroid syringomas are needed in order to determine whether genetic heterogeneity exists among them and the clinical impact of the PHF1-TFE3 fusion. Copyright
BACKGROUND/AIM: Malignant chondroid syringoma is a rare tumor of unknown pathogenesis. MATERIALS AND METHODS: Genetic analyses were performed on a malignant chondroid syringoma. RESULTS: G-banding analysis of short-term cultured tumor cells yielded the karyotype 46,Y,t(X;6)(p11;p21)[15]/46,XY[2]. RNA sequencing detected an in-frame fusion of PHF1 from 6p21 with TFE3 from Xp11, verified by RT-PCR and Sanger sequencing. Genomic PCR showed that the PHF1-TFE3 junction was identical to the fusion found by RNA sequencing and RT-PCR. CONCLUSION:Malignant chondroid syringoma is genetically related to tumors with PHF1 rearrangements such as low-grade endometrial sarcoma and ossifying fibromyxoid tumor, but also with tumors having TFE3 rearrangements such as renal cell carcinoma, alveolar soft part sarcoma, PEComa, and epithelioid hemangioendothelioma. Further investigations on malignant chondroid syringomas are needed in order to determine whether genetic heterogeneity exists among them and the clinical impact of the PHF1-TFE3 fusion. Copyright
Authors: S K Sidhar; J Clark; S Gill; R Hamoudi; A J Crew; R Gwilliam; M Ross; W M Linehan; S Birdsall; J Shipley; C S Cooper Journal: Hum Mol Genet Date: 1996-09 Impact factor: 6.150
Authors: Narasimhan P Agaram; Yun-Shao Sung; Lei Zhang; Chun-Liang Chen; Hsiao-Wei Chen; Samuel Singer; Mark A Dickson; Michael F Berger; Cristina R Antonescu Journal: Am J Surg Pathol Date: 2015-06 Impact factor: 6.394
Authors: Pedram Argani; Minghao Zhong; Victor E Reuter; John T Fallon; Jonathan I Epstein; George J Netto; Cristina R Antonescu Journal: Am J Surg Pathol Date: 2016-06 Impact factor: 6.394
Authors: Nicolas Macagno; Pierre Sohier; Thibault Kervarrec; Daniel Pissaloux; Marie-Laure Jullie; Bernard Cribier; Maxime Battistella Journal: Cancers (Basel) Date: 2022-01-18 Impact factor: 6.639
Authors: Iga Płachta; Marcin Kleibert; Anna M Czarnecka; Mateusz Spałek; Anna Szumera-Ciećkiewicz; Piotr Rutkowski Journal: Int J Mol Sci Date: 2021-05-11 Impact factor: 5.923